NCT02470221

Brief Summary

This study is aim to assess the effect of goal-directed intraoperative fluid therapy on patient's postoperative incidence rates of complications, length of hospitalization and hospitalization cost. This is an observational study followed cohort study design, due to the two therapies were not randomized assigned to the two cohorts. The details are described as follow.

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
600

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Mar 2016

Typical duration for all trials

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 28, 2015

Completed
15 days until next milestone

First Posted

Study publicly available on registry

June 12, 2015

Completed
9 months until next milestone

Study Start

First participant enrolled

March 1, 2016

Completed
1.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 10, 2018

Completed
5 months until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2018

Completed
Last Updated

May 31, 2019

Status Verified

May 1, 2019

Enrollment Period

1.9 years

First QC Date

May 28, 2015

Last Update Submit

May 29, 2019

Conditions

Keywords

goal-directed fluid therapyintraoperative hemodynamicspostoperative complications

Outcome Measures

Primary Outcomes (1)

  • postoperative complications

    the incidence of complications related to surgeries 30 days postoperatively. The complications include pneumonia, pulmonary embolism, cardiovascular events (myocardial infarction, heart failure), wound infection, gastrointestinal bleeding,nausea and vomitting,postoperative hemorrhage, ileus, deep venous thrombosis, cerebral infarction, cerebral embolism, cerebral hemorrhage, renal insufficiency and failure. Those complications are defined strictly to the reference published in 2009 New England Journal of Medicine (N Engl J Med. 2009 Oct 1;361:1368-75)

    30 days after the surgery

Secondary Outcomes (2)

  • hospital length of stay

    participants will be followed for the duration of hospital stay, an expected average of 10 days

  • hospital expenses

    30 days after the surgery

Study Arms (2)

Goal-directed fluid therapy

The fluid in group Goal-directed fluid therapy will be administered based upon real-time monitoring stroke volume variation and cardiac output achieved by the Flo-Trac monitoring system.

Other: Applying goal-directed fluid therapy by continuous hemodynamic monitoring system

Conventional fluid therapy

The fluid in group Conventional fluid therapy will be administered based on the principle crystalloid solution: colloid solution =2-3:1. The total volume of fluid will be adjusted in accordance with blood pressure, heart rate and urine output of each patient.

Other: Conventional fluid therapy

Interventions

Applying continuous hemodynamic monitoring system ( Vigileo/Flotrac) to monitor Stroke Volume Variation and Cardiac Output and further manage intra-operative fluid therapy.

Goal-directed fluid therapy

Applying conventional fluid therapy according to Peking Union Medical College Hospital standard.

Conventional fluid therapy

Eligibility Criteria

Age18 Years - 90 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients underwent either laparotomy of gynecological malignancies or orthopedic surgery

You may qualify if:

  • Receiving elective laparotomy of gynecological malignancies (LGM): including cytoreductive surgery of ovarian cancer, radical hysterectomy and staging surgery of endometrial cancer ;
  • Major elective orthopedic surgery (OS): including spinal surgery, revision surgery of hip joints ;
  • Age ≥18 years, American Society of Anesthesiologists physical status I ~IV;
  • No arrhythmia;
  • Receiving general anesthesia;
  • Requiring monitoring of direct blood pressure due to the comorbidities of patients and the nature of surgical procedures.

You may not qualify if:

  • Emergent surgery;
  • Patients with aortic regurgitation;
  • Patients with aortic stenosis, peripheral arterial diseases or other diseases contradicting to arterial canalizations;
  • Patients with mental disorders or low intelligence quotient; patients who cannot cooperate or refuse to sign the consent.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (6)

  • Cecconi M, Fasano N, Langiano N, Divella M, Costa MG, Rhodes A, Della Rocca G. Goal-directed haemodynamic therapy during elective total hip arthroplasty under regional anaesthesia. Crit Care. 2011;15(3):R132. doi: 10.1186/cc10246. Epub 2011 May 30.

    PMID: 21624138BACKGROUND
  • Kuper M, Gold SJ, Callow C, Quraishi T, King S, Mulreany A, Bianchi M, Conway DH. Intraoperative fluid management guided by oesophageal Doppler monitoring. BMJ. 2011 May 24;342:d3016. doi: 10.1136/bmj.d3016.

    PMID: 21610051BACKGROUND
  • Wang P, Wang HW, Zhong TD. Effect of stroke volume variability- guided intraoperative fluid restriction on gastrointestinal functional recovery. Hepatogastroenterology. 2012 Nov-Dec;59(120):2457-60. doi: 10.5754/hge12283.

    PMID: 22626878BACKGROUND
  • Ramsingh DS, Sanghvi C, Gamboa J, Cannesson M, Applegate RL 2nd. Outcome impact of goal directed fluid therapy during high risk abdominal surgery in low to moderate risk patients: a randomized controlled trial. J Clin Monit Comput. 2013 Jun;27(3):249-57. doi: 10.1007/s10877-012-9422-5. Epub 2012 Dec 22.

    PMID: 23264068BACKGROUND
  • Donati A, Loggi S, Preiser JC, Orsetti G, Munch C, Gabbanelli V, Pelaia P, Pietropaoli P. Goal-directed intraoperative therapy reduces morbidity and length of hospital stay in high-risk surgical patients. Chest. 2007 Dec;132(6):1817-24. doi: 10.1378/chest.07-0621. Epub 2007 Oct 9.

    PMID: 17925428BACKGROUND
  • Che L, Zhang XH, Li X, Zhang YL, Xu L, Huang YG. Outcome impact of individualized fluid management during spine surgery: a before-after prospective comparison study. BMC Anesthesiol. 2020 Jul 22;20(1):181. doi: 10.1186/s12871-020-01092-w.

MeSH Terms

Conditions

Postoperative ComplicationsEdema

Condition Hierarchy (Ancestors)

Pathologic ProcessesPathological Conditions, Signs and SymptomsSigns and Symptoms

Study Officials

  • Yuguang Huang, MD

    Peking Union Medical College Hospital

    STUDY CHAIR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Professor,Chairman

Study Record Dates

First Submitted

May 28, 2015

First Posted

June 12, 2015

Study Start

March 1, 2016

Primary Completion

February 10, 2018

Study Completion

July 1, 2018

Last Updated

May 31, 2019

Record last verified: 2019-05